Bright Minds Biosciences Inc. · CSE:DRUG
Vivo Opportunity Fund Holdings, L.P. reported a 5.20% stake in Bright Minds Biosciences Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 12, 2026
Vivo Opportunity Fund Holdings, L.P. reported a 5.20% stake in Bright Minds Biosciences Inc., 504,645 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G/A).
- Stake
- 5.20%
- Shares
- 504,645
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 5.20% | 504,645 |
| Vivo Opportunity, LLC | 5.20% | 504,645 |
| Vivo Opportunity Cayman Fund, L.P. | 0.50% | 52,527 |
| Vivo Opportunity Cayman, LLC | 0.50% | 52,527 |
Source
Related
- Bright Minds Biosciences Inc.
- Vivo Opportunity, LLC
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G · Vivo Opportunity, LLC · Nov 14, 2025
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026